Cytori Therapeutics

Cytori Therapeutics, Inc. is dedicated to developing and delivering innovative cell-based therapies to improve the quality and length of life. We are a global, public company engaged in the development and commercialization of stem and regenerative cell therapies for the treatment of cardiovascular disease, reconstructive surgery and other serious, chronic, and life threatening conditions.

Company Growth (employees)
Type
Public
HQ
San Diego, US
Founded
1996
Size (employees)
80 (est)
Cytori Therapeutics was founded in 1996 and is headquartered in San Diego, US

Cytori Therapeutics Office Locations

Cytori Therapeutics has offices in San Diego, Flintshire, Minato-ku
San Diego, US
Minato-ku, JP
Flintshire, GB

Cytori Therapeutics Metrics

Cytori Therapeutics Summary

Market capitalization

$33.8 m

Closing share price

$1.7
Cytori Therapeutics's current market capitalization is $33.8 m.

Cytori Therapeutics Financials

Cytori Therapeutics's revenue is $4.8 m in FY, 2015 which is a 2.3% decrease from the previous period.
FY, 2013FY, 2014FY, 2015

Revenue

$7.1 m$5 m$4.8 m

Revenue growth, %

(30.5%)(2.3%)

Gross profit

$3.7 m$2 m$1.7 m

Operating expense total

$39.5 m$37.1 m$23.8 m

EBIT

($30.6 m)($32.4 m)($15.3 m)

Net Income

($26.2 m)($37.4 m)($18.7 m)

Operating cash flow

($10.2 m)($884 k)($284 k)

Cytori Therapeutics Market Value History

Cytori Therapeutics Online Presence

Cytori Therapeutics News

Cytori Therapeutics Company Life

You may also be interested in